Blog
Innovative Industrial Properties Acquires Virginia Property
Innovative Industrial Properties (NYSE: IIPR), the lone publicly traded real estate investment trust (REIT) specializing in the cannabis industry, is adding another asset to its portfolio.
The
Better Buy: Universal Display vs. Corning
Just as there are many ways to scalp a feline, there are plenty of ways to invest in the digital display market. Two popular choices involve glass and ceramics materials specialist Corning (NYSE:
You're Probably Spending Too Much on These 7 Things
Wasting a little money from time to time proves you're only human, but that doesn't mean you should spend with reckless abandon. Everyone should occasionally take time to comb through their budget
This Beaten-Down Software Stock Has a New CEO: Time to Buy?
Shares of open-source big data software company Cloudera (NYSE: CLDR) had been without a permanent CEO ever since former CEO Tom Reilly announced his resignation back in June. However, on Jan. 13
Better Buy: Cisco Systems vs. IBM
These days, the tech industry isn't short of non-profitable, high-growth companies. But if you prefer to invest in solid free-cash-flow machines that should still be able to pay a generous dividend
Forget AT&T -- Enbridge Is a Better Dividend Stock
Telecom and media powerhouse AT&T (NYSE: T) is a rock-solid dividend stock for retirement-focused investors. It sports an attractive 5.5% yield, which is more than twice what the average
Here’s the Winner of Fourth-Quarter Bank Earnings
The big U.S. banks are among the first companies to report their results each earnings season, and we've now kicked off fourth-quarter 2019 earnings season with a flurry of bank reports. Some have
Why AbbVie Stock Dipped in 2019
Shares of pharma giant AbbVie (NYSE: ABBV) dipped by 3.96% over the course of 2019, according to data from S&P Global Market Intelligence. The drugmaker's stock slipped last year for two fundamental
PriceSmart Tells Investors Its Spending Plan Is Working
PriceSmart (NASDAQ: PSMT) last week announced first-quarter results that kept the warehouse retailer on pace to achieve modest sales and profit growth in fiscal 2020. Yet management is even more
Where Will Albemarle Be in 1 Year?
Albemarle's (NYSE: ALB) stock is down nearly 50% from the highs it reached in late 2017. Although production increases have kept the world's leading lithium producer's earnings heading higher
This Company Will Dominate the Next Era of Data Centers
A decade ago, software-defined networking wasn't much more than an idea.
Traditional networking and data center hardware names like Cisco (NASDAQ: CSCO) and the company that would eventually turn
Should You Start Your Own Business in 2020?
There's nothing wrong with working for an employer and reporting to a boss who calls the shots. But if you're an independent worker by nature and prefer to run your own show, starting your own
Netflix Earnings: 3 Questions for CEO Reed Hastings
Netflix (NASDAQ: NFLX) is a controversial stock in the investment community for several reasons, not least of which is the increasing number of rival offerings from Disney (NYSE: DIS), Apple
3 Things to Watch When Atlassian Reports Earnings Next Week
The past three months have been a tumultuous time for investors in Atlassian (NASDAQ: TEAM). Even though the work-productivity software specialist delivered a better-than-expected earnings report
Online Dating Is Exploding: Can Match Group Live Up to Its Lofty Expectations?
Match Group (NASDAQ: MTCH), a global leader in dating apps such as Tinder, Match, and OKCupid, certainly has its work cut out for it. Online dating has seen a boom in recent years as more and more
This Oil Giant Is Still Cheap Despite Its Growth Potential
ExxonMobil (NYSE: XOM) doesn't get a lot of respect in today's market as its heavy spending to boost production has yet to generate notable improvements. That could be about to change. Here are a
Made a Healthcare Coverage Mistake? You're in Good Company
The health insurance plan you choose will largely dictate your out-of-pocket medical spending during the year, so it pays to put lots of thought into that decision. Unfortunately, a large percentage
Why It’s (Kind Of) Different This Time for Micron Stock
Some investors may cringe when they hear the words, "it's different this time." Indeed, the history of Micron (NASDAQ: MU) stock has given investors reasons to be wary. Rather than rising over a
The Huge Retirement Risk You Probably Don't Realize You're Facing
When you consider the risks you face in retirement, most of them probably center around finances. Some people may be worried about not saving enough, while others are concerned about the rising
The Mobile Economy Had a Monster 2019
The mobile revolution isn't over yet. Quite the contrary -- more aspects of the average consumer's life, including areas like personal finance and digital health data, continue to shift onto mobile
2 Things Nordstrom Is Doing Right to Survive the Retail Shakedown
The retail apocalypse is devastating department stores and other retailers across the country. In 2019, there were more than 9,300 store closures in the U.S. To survive, a company must make
Tencent Expands Overseas Again With a Stake in Bayonetta’s Developer
Tencent (OTC: TCEHY), the world's largest game publisher, recently took a stake in PlatinumGames, the Japanese developer of Bayonetta and Nier: Automata. This marks Tencent's first investment in a
3 Stocks to Avoid at All Costs
As the stock market marches ever higher, it's been harder and harder to find reasonably valued equities to purchase. Some stocks have been beaten down unfairly, while others are on the verge of
Is the Vanguard High Dividend Yield ETF a Buy?
The Vanguard High Dividend Yield ETF (NYSEMKT: VYM) has long been a go-to vehicle for investors seeking diversified exposure to income-generating stocks. The exchange-traded fund (ETF) combines 404
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Investing in biotech stocks can seem like a speculative gamble on binary outcomes, sort of like buying lottery tickets. Fortunately, there are some mid-cap biotechs actually making a profit and that


